Recent Advances in Autoimmune Rheumatic Diseases: 2nd Edition

Dear Colleagues,

Autoimmune rheumatic diseases are the leading cause of disability worldwide, with major financial and social consequences for all societies. The number of people suffering from autoimmune rheumatic diseases is increasing, especially in more economically developed countries. Autoimmune rheumatic diseases are a group of diseases characterised by heterogeneous clinical, laboratory and immunological manifestations. The pathogenesis of autoimmune rheumatic diseases is not fully understood, but recent research recognises that the pathogenesis of autoimmune rheumatic diseases is multifactorial. This encourages patient-centered collaboration between clinicians and researchers.

This Special Issue focuses on the latest advances in autoimmune rheumatic diseases, with the hope that it will significantly contribute to clinical practice, improve public health, and share up-to-date information on the latest advances in autoimmune rheumatic diseases. We kindly invite you to submit your original research, review articles and case reports for this Special Issue.

Dr. Diana Mieliauskaitė
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• autoimmune rheumatic diseases
• rheumatoid arthritis
• systemic lupus erythematosus
• Sjogren’s disease
• systemic scleroderma
• psoriatic arthritis
• mixed connective tissue disease
• ankylosing spondylitis
• vasculitides
• juvenile arthritis
• rare autoimmune rheumatic diseases

• Recent Advances in Autoimmune Rheumatic Diseases in Medicina (9 articles)